3-Amino-5-fluoro-4-methylbenzoic acid, 95.0%, 100mg

1-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

3,3'-Di-tert-butyl-2'-((4,8-di-tert-butyl-2,10-dimethoxydibenzo[d,f][1,3,2]dioxaphosphepin-6-yl)oxy)-5,5'-dimethoxy-[1,1'-biphenyl]-2-ol, 97%, 1g

3,5-Diphenylpyridine, 95.0%, 1g

2-(4-Bromo-3-fluorophenyl)-2-methylpropanenitrile, 98%, 5g

Phenanthren-3-amine, 95.0%, 10g

2-Bromoethyl methyl ether (stabilised with Potassium Carbonate), 99.0%, 25g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, 95.0%, 5g

Z-3-(1-naphthyl)-D-alanine, 99.0%, 1g

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oic acid, 98%, 25g

5,7-Dimethyl-3,4-dihydronaphthalen-1(2h)-one, 95+%, 10g

3-Bromo-4-(trifluoromethoxy)phenol, 95.0%, 5g

Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] Oxalate>98.0%(HPLC)25g